Myocardial Fibrosis Clinical Trials

7 recruiting

Myocardial Fibrosis Trials at a Glance

8 actively recruiting trials for myocardial fibrosis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Baltimore, Cincinnati, and Coimbra. Lead sponsors running myocardial fibrosis studies include Johann Wolfgang Goethe University Hospital, Johns Hopkins University, and Children's Hospital Medical Center, Cincinnati.

Browse myocardial fibrosis trials by phase

Treatments under study

About Myocardial Fibrosis Clinical Trials

Looking for clinical trials for Myocardial Fibrosis? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Myocardial Fibrosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Myocardial Fibrosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

HFpEFMyocardial FibrosisLVDD
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation50 enrolled1 locationNCT06655480
Recruiting
Phase 4

High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment

Myocardial Fibrosis
Johns Hopkins University25 enrolled2 locationsNCT05954559
Recruiting
Phase 1

Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

CardiomyopathiesFriedreich AtaxiaMyocardial Fibrosis+1 more
Weill Medical College of Cornell University25 enrolled1 locationNCT05302271
Recruiting
Phase 2

Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

Sickle Cell DiseaseDiffuse Myocardial Fibrosis
Children's Hospital Medical Center, Cincinnati24 enrolled1 locationNCT05012631
Recruiting

IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION

Heart FailureLong COVID SyndromeMyocarditis+2 more
Johann Wolfgang Goethe University Hospital6,000 enrolled1 locationNCT04444128
Recruiting

⁶⁸Ga-FAPI PET/CT for Cardiac Fibrosis in Heart Failure

Heart FailureMyocardial Fibrosis
University of Coimbra30 enrolled1 locationNCT07296081
Recruiting

Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm

Acute Myocardial InfarctionMyocardial FibrosisVentricular Aneurysm Following Acute Myocardial Infarction
RenJi Hospital20 enrolled1 locationNCT06994221
Recruiting

Response of the Myocardium to Hypertrophic Conditions in the Adult Population

HypertensionLeft Ventricular HypertrophyMyocardial Fibrosis
National Heart Centre Singapore2,000 enrolled1 locationNCT02670031